Electrosurgery and Other Technical Advancements in Minimally Invasive Gynecological Surgery - An Update.


Journal

Surgical technology international
ISSN: 1090-3941
Titre abrégé: Surg Technol Int
Pays: United States
ID NLM: 9604509

Informations de publication

Date de publication:
19 May 2022
Historique:
pubmed: 21 4 2022
medline: 24 5 2022
entrez: 20 4 2022
Statut: ppublish

Résumé

Electrosurgery in gynecology has changed over the past few decades. The use of energy-based devices, especially in minimally invasive procedures, is extremely important for preparation, short reconvalescence and patient safety. Recently, there have been major advances in energy-based surgical devices that have further shortened OR time and increased patient safety. Although bipolar and monopolar electrosurgery is still very important, the introduction of high-frequency ultrasound in gynecologic surgery has improved cutting and coagulation by lowering thermal damage in the surrounding tissue. Furthermore, new technical inventions have fundamentally changed the treatment of specific diseases. The introduction of ablation in the therapy of uterine fibroids, for example, has made conventional myomectomy no longer necessary in some cases, as necrosis of fibroids can be induced by placing very small thermal probes into the fibroids. Robotic surgery will change the face of gynecological surgery in the near future, as the initial studies could show lower surgical morbidity and faster recovery of patients after robotic-assisted laparoscopy. In this article we provide a short overview of current technical advances, review possible indications as well as limitations, and take a look into the future of minimally invasive surgery in gynecology.

Identifiants

pubmed: 35443283
pii: sti40/1544
doi: 10.52198/22.STI.40.GY1544

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-196

Auteurs

Marcel Grube (M)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Martin Weiss (M)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Christina B Walter (CB)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Felix Neis (F)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Sascha Hoffmann (S)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Juergen Andress (J)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Stefan Kommoss (S)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Sara Y Brucker (SY)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Bernhard Krämer (B)

Department of Women's Health, Tuebingen University Hospital, Tuebingen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH